pharma · Allergy · Allergic rhinoconjunctivitis
A. MENARINI MANUFACTURING
A. Menarini Industrie Farmaceutiche Riunite s.r.l.
A. Menarini Industrie is a pharma organization headquartered in FIRENZE, IT. Primary therapeutic focus areas include Allergy, Allergic rhinoconjunctivitis. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), a
Company details
- Status
- Public
- HQ
- Florence, IT
- Employees
- 122
- Programs
- 2
- Drugs
- 6
- Patents
- 5
Bilaxten Flas 10 mg comprimidos bucodispersables
Approved · small molecule · Allergic rhinoconjunctivitis
Bilaxten Flas 10 mg comprimidos bucodispersables for Allergic rhinoconjunctivitis is a Approved program (small_molecule) at A. Menarini Industrie Farmaceutiche Riunite s.r.l. with 1 ClinicalTrials.gov record(s).
Internal code BILA-4124/PED
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- A. Menarini Industrie Farmaceutiche Riunite s.r.l.
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Allergic rhinoconjunctivitis
- Status
- active
- Trials
- 1